NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

自身免疫性疾病診斷的全球市場(按產品,測試類型,應用,最終用戶):工業分析和增長預測(到2030年)

Autoimmune Disease Diagnostics Market Research Report: By Product, Test Type, Application, End User - Industry Analysis and Growth Forecast to 2030

出版商 Prescient & Strategic Intelligence Private Limited 商品編碼 968431
出版日期 內容資訊 英文 266 Pages
商品交期: 2-3個工作天內
價格
自身免疫性疾病診斷的全球市場(按產品,測試類型,應用,最終用戶):工業分析和增長預測(到2030年) Autoimmune Disease Diagnostics Market Research Report: By Product, Test Type, Application, End User - Industry Analysis and Growth Forecast to 2030
出版日期: 2020年07月01日內容資訊: 英文 266 Pages
簡介
在2020年至2030年之間,全球自身免疫性疾病診斷市場預計將以8.5%的複合年增長率增長,到2030年將達到100.129億美元。市場的主要驅動力是老年人口的增加,自身免疫疾病的發病率增加,公共和私營部門的提高認識活動的進展,生物標誌物的發現以及大型公司的積極業務發展。

本報告分析了自身免疫性疾病診斷劑的全球市場,並概述了疾病,產品和市場的背景,市場的基本結構,主要的市場促銷/抑制因素以及實際的市場規模。我們正在調查預測值(未來11年),按產品,檢查類型,應用,最終用戶和地區劃分的詳細趨勢,市場競爭狀況,主要公司的概況等。

目錄

目錄

第1章分析背景

第2章分析方法

第3章執行摘要

第4章簡介

  • 市場細分的定義
    • 副產品
      • 耗材/分析試劑盒
      • 診斷設備
    • 按檢查類型
      • 例行檢查
      • 炎症標記
      • 自身抗體/免疫測試
      • HLA(人類白細胞抗原)
      • 細胞因子
      • 流式細胞儀
      • 其他
    • 按應用
      • 風濕性關節炎(RA)
      • 多發性硬化症
      • SLE(系統性紅斑)
      • Schegren綜合徵
      • 強烈的皮膚病
      • 重症肌無力
      • 結節病
      • 其他
    • 最終用戶
      • 醫院
      • 診斷中心
      • 教育機構/研究中心
      • 其他
  • 市場動態
    • 趨勢
      • 發現新的生物標記
      • 戰略發展數量增加
    • 促進因素
      • 自身免疫疾病的廣泛負擔
      • 對自身免疫性疾病的認識提高
      • 醫療費用增加
      • 驅動因素對市場預測的影響分析
    • 抑製器
      • 診斷設備的高購置和維護成本
      • 分析限制因素對市場預測的影響
    • 市場機會
      • 認識和深入研究以確定自身免疫性疾病
  • 波特的五力分析
  • COVID-19的影響

第5章世界市場:市場規模和預測

  • 副產品
    • 消耗品/分析試劑盒:按類型
    • 診斷設備:按類型
  • 按檢查類型
  • 按應用
  • 最終用戶
  • 按地區

第6章北美市場:市場規模和預測

  • 副產品
  • 按檢查類型
  • 按應用
  • 最終用戶
  • 按國家
    • 美國市場
    • 加拿大市場

第7章歐洲市場:市場規模和預測

  • 按國家
    • 德國市場
    • 法國市場
    • 英國市場
    • 意大利市場
    • 西班牙市場

第8章亞太市場:市場規模和預測

  • 按國家
    • 中國市場
    • 印度市場
    • 日本市場

第9章拉丁美洲市場:市場規模和預測

第10章中東/非洲市場:市場規模和預測

第11章競爭情況

  • 主要公司的市場份額分析
  • 大型公司產品的相互比較
  • 市場策略的發展現狀

第12章公司簡介

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Siemens AG
  • Grifols S.A.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • DiaSorin S.p.A.
  • Trinity Biotech plc
  • bioMerieux S.A.
  • A. Menarini Diagnostics S.r.l.
  • Cambridge Life Sciences Limited
  • Seramun Diagnostica GmbH
  • Exagen Inc.
  • HYCOR Biomedical
  • ELITech Group
  • Inova Diagnostics
  • Adaltis S.r.l.
  • ORGENTEC Diagnostika GmbH
  • Sigma Diagnostics Inc.

第13章 附錄

目錄
Product Code: LS12048

Title:
Autoimmune Disease Diagnostics Market Research Report: By Product (Consumables and Assay Kits, Instruments), Test Type (Routine Laboratory, Inflammatory Marker, Autoantibodies and Immunology, Human Leukocyte Antigen, Cytokine, Flow Cytometry), Application (Rheumatoid Arthritis, Multiple Sclerosis, Systemic Lupus Erythematosus, SjA¶grena€™s Syndrome, Scleroderma, Myasthenia Gravis, Sarcoidosis), End User (Hospitals, Diagnosing Centers, Academic Institutes and Research Centers) - Industry Analysis and Growth Forecast to 2030.

According to a report by P&S Intelligence, the global autoimmune disease diagnostics market is projected to generate a revenue of $10,012.9 million by 2030, and is predicted to progress at an 8.5% CAGR during the time period 2020-2030. The market is being driven by the increasing geriatric population, rising incidence of autoimmune diseases, growing initiatives taken by various government and private organizations for raising awareness regarding autoimmune diseases, discovery of biomarkers, and surging strategic developments among major players.

On the basis of application, the autoimmune disease diagnostic market is divided into multiple sclerosis, rheumatoid arthritis (RA), systemic lupus erythematous, scleroderma, Sjogren's syndrome, sarcoidosis, myasthenia gravis, and others. Out of all these, the RA division is projected to register the highest CAGR in the near future, which can be attributed to the rising awareness programs that are being organized by public and private organizations, growing cases of RA, and discovery of new biomarkers for the diagnosis of this diseases.

Geographically, North America is predicted to advance at the fastest pace in the coming years in the autoimmune disease diagnostics market. This can be owing to the widespread burden of autoimmune diseases, enhanced healthcare infrastructure, presence of established players, growing geriatric population, and rising research activities.

The major players operating in the autoimmune disease diagnostics market are Abbott Laboratories, Thermo Fisher Scientific Inc., bioMerieux S.A., Danaher Corporation, Siemens AG, Seramun Diagnostica GmbH, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Trinity Biotech plc, Exagen Inc., Cambridge Life Sciences Limited, , HYCOR Biomedical, Grifols S.A., ELITech Group, PerkinElmer Inc., Inova Diagnostics, Adaltis S.r.l., ORGENTEC Diagnostika GmbH, Bio-Rad Laboratories Inc., Sigma Diagnostics Inc., and A. Menarini Diagnostics S.r.l.

Table of Contents

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Product
    • 1.3.2 Market Segmentation by Test Type
    • 1.3.3 Market Segmentation by Application
    • 1.3.4 Market Segmentation by End User
    • 1.3.5 Market Segmentation by Region
    • 1.3.6 Analysis Period
    • 1.3.7 Market Data Reporting Unit
      • 1.3.7.1 Value
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
    • 2.1.1 Paid
    • 2.1.2 Unpaid
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By region
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Currency Conversion Rates
  • 2.6 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Product
      • 4.1.1.1 Consumables and assay kits
        • 4.1.1.1.1 ELISA
        • 4.1.1.1.2 ANA IFA
        • 4.1.1.1.3 RF and anti-CCP antibody
        • 4.1.1.1.4 Others
      • 4.1.1.2 Instruments
        • 4.1.1.2.1 Automated
        • 4.1.1.2.2 Semi-automated
    • 4.1.2 By Test Type
      • 4.1.2.1 Routine laboratory
      • 4.1.2.2 Inflammatory marker
      • 4.1.2.3 Autoantibodies and immunology
      • 4.1.2.4 HLA
      • 4.1.2.5 Cytokine
      • 4.1.2.6 Flow cytometry
      • 4.1.2.7 Others
    • 4.1.3 By Application
      • 4.1.3.1 RA
      • 4.1.3.2 Multiple sclerosis
      • 4.1.3.3 SLE
      • 4.1.3.4 Sjogren's syndrome
      • 4.1.3.5 Scleroderma
      • 4.1.3.6 Myasthenia gravis
      • 4.1.3.7 Sarcoidosis
      • 4.1.3.8 Others
    • 4.1.4 By End User
      • 4.1.4.1 Hospitals
      • 4.1.4.2 Diagnostic centers
      • 4.1.4.3 Academic institutes and research centers
      • 4.1.4.4 Others
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Discovering new biomarkers
      • 4.2.1.2 Increasing strategic developments
    • 4.2.2 Drivers
      • 4.2.2.1 Widespread burden of autoimmune diseases
      • 4.2.2.2 Increasing awareness about autoimmune diseases
      • 4.2.2.3 Rising healthcare expenditure
      • 4.2.2.4 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 High purchase and maintenance cost of instruments
      • 4.2.3.2 Impact analysis of restraints on market forecast
    • 4.2.4 Opportunities
      • 4.2.4.1 Awareness and extensive studies to identify autoimmune diseases
  • 4.3 Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Buyers
    • 4.3.2 Bargaining Power of Suppliers
    • 4.3.3 Intensity of Rivalry
    • 4.3.4 Threat of New Entrants
    • 4.3.5 Threat of Substitutes
  • 4.4 Impact of COVID-19

Chapter 5. Global Market Size and Forecast

  • 5.1 By Product
    • 5.1.1 Consumables and Assay Kits, by Type
    • 5.1.2 Instruments, by Type
  • 5.2 By Test Type
  • 5.3 By Application
  • 5.4 By End User
  • 5.5 By Region

Chapter 6. North America Market Size and Forecast

  • 6.1 By Product
    • 6.1.1 Consumables and Assay Kits, by Type
    • 6.1.2 Instruments, by Type
  • 6.2 Test Type
  • 6.3 By Application
  • 6.4 By End User
  • 6.5 By Country
    • 6.5.1 U.S. Autoimmune Disease Diagnostics Market
      • 6.5.1.1 By product
        • 6.5.1.1.1 Consumables and assay kits, by type
        • 6.5.1.1.2 Instruments, by type
      • 6.5.1.2 By test type
      • 6.5.1.3 By application
      • 6.5.1.4 By end user
    • 6.5.2 Canada Autoimmune Disease Diagnostics Market
      • 6.5.2.1 By product
        • 6.5.2.1.1 Consumables and assay kits, by type
        • 6.5.2.1.2 Instruments, by type
      • 6.5.2.2 By test type
      • 6.5.2.3 By application
      • 6.5.2.4 By end user

Chapter 7. Europe Market Size and Forecast

  • 7.1 By Product
    • 7.1.1 Consumables and Assay Kits, by Type
    • 7.1.2 Instruments, by Type
  • 7.2 By Test Type
  • 7.3 By Application
  • 7.4 By End User
  • 7.5 By Country
    • 7.5.1 Germany Autoimmune Disease Diagnostics Market
      • 7.5.1.1 By product
        • 7.5.1.1.1 Consumables and assay kits, by type
        • 7.5.1.1.2 Instruments, by type
      • 7.5.1.2 By test type
      • 7.5.1.3 By application
      • 7.5.1.4 By end user
    • 7.5.2 France Autoimmune Disease Diagnostics Market
      • 7.5.2.1 By product
        • 7.5.2.1.1 Consumables and assay kits, by type
        • 7.5.2.1.2 Instruments, by type
      • 7.5.2.2 By test type
      • 7.5.2.3 By application
      • 7.5.2.4 By end user
    • 7.5.3 U.K. Autoimmune Disease Diagnostics Market
      • 7.5.3.1 By product
        • 7.5.3.1.1 Consumables and assay kits, by type
        • 7.5.3.1.2 Instruments, by type
      • 7.5.3.2 By test type
      • 7.5.3.3 By application
      • 7.5.3.4 By end user
    • 7.5.4 Italy Autoimmune Disease Diagnostics Market
      • 7.5.4.1 By product
        • 7.5.4.1.1 Consumables and assay kits, by type
        • 7.5.4.1.2 Instruments, by type
      • 7.5.4.2 By test type
      • 7.5.4.3 By application
      • 7.5.4.4 By end user
    • 7.5.5 Spain Autoimmune Disease Diagnostics Market
      • 7.5.5.1 By product
        • 7.5.5.1.1 Consumables and assay kits, by type
        • 7.5.5.1.2 Instruments, by type
      • 7.5.5.2 By test type
      • 7.5.5.3 By application
      • 7.5.5.4 By end user

Chapter 8. APAC Market Size and Forecast

  • 8.1 By Product
    • 8.1.1 Consumables and Assay Kits, by Type
    • 8.1.2 Instruments, by Type
  • 8.2 By Test Type
  • 8.3 By Application
  • 8.4 By End User
  • 8.5 By Country
    • 8.5.1 China Autoimmune Disease Diagnostics Market
      • 8.5.1.1 By product
        • 8.5.1.1.1 Consumables and assay kits, by type
        • 8.5.1.1.2 Instruments, by type
      • 8.5.1.2 By test type
      • 8.5.1.3 By application
      • 8.5.1.4 By end user
    • 8.5.2 India Autoimmune Disease Diagnostics Market
      • 8.5.2.1 By product
        • 8.5.2.1.1 Consumables and assay kits, by type
        • 8.5.2.1.2 Instruments, by type
      • 8.5.2.2 By test type
      • 8.5.2.3 By application
      • 8.5.2.4 By end user
    • 8.5.3 Japan Autoimmune Disease Diagnostics Market
      • 8.5.3.1 By product
        • 8.5.3.1.1 Consumables and assay kits, by type
        • 8.5.3.1.2 Instruments, by type
      • 8.5.3.2 By test type
      • 8.5.3.3 By application
      • 8.5.3.4 By end user

Chapter 9. LATAM Market Size and Forecast

  • 9.1 By Product
    • 9.1.1 Consumables and Assay Kits, by Type
    • 9.1.2 Instruments, by Type
  • 9.2 By Test Type
  • 9.3 By Application
  • 9.4 By End User
  • 9.5 By Country

Chapter 10. MEA Market Size and Forecast

  • 10.1 By Product
    • 10.1.1 Consumables and Assay Kits, by Type
    • 10.1.2 Instruments, by Type
  • 10.2 By Test Type
  • 10.3 By Application
  • 10.4 By End User
  • 10.5 By Country

Chapter 11. Competitive Landscape

  • 11.1 Market Share Analysis of Key Players
  • 11.2 Product Benchmarking of Key Players
  • 11.3 Strategic Developments in the Market

Chapter 12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Business Overview
    • 12.1.2 Product and Service Offerings
    • 12.1.3 Key Financial Summary
  • 12.2 Bio-Rad Laboratories Inc.
    • 12.2.1 Business Overview
    • 12.2.2 Product and Service Offerings
    • 12.2.3 Key Financial Summary
  • 12.3 Thermo Fisher Scientific Inc.
    • 12.3.1 Business Overview
    • 12.3.2 Product and Service Offerings
    • 12.3.3 Key Financial Summary
  • 12.4 Siemens AG
    • 12.4.1 Business Overview
    • 12.4.2 Product and Service Offerings
    • 12.4.3 Key Financial Summary
  • 12.5 Grifols S.A.
    • 12.5.1 Business Overview
    • 12.5.2 Product and Service Offerings
    • 12.5.3 Key Financial Summary
  • 12.6 Danaher Corporation
    • 12.6.1 Business Overview
    • 12.6.2 Product and Service Offerings
    • 12.6.3 Key Financial Summary
  • 12.7 F. Hoffmann-La Roche Ltd.
    • 12.7.1 Business Overview
    • 12.7.2 Product and Service Offerings
    • 12.7.3 Key Financial Summary
  • 12.8 PerkinElmer Inc.
    • 12.8.1 Business Overview
    • 12.8.2 Product and Service Offerings
    • 12.8.3 Key Financial Summary
  • 12.9 DiaSorin S.p.A.
    • 12.9.1 Business Overview
    • 12.9.2 Product and Service Offerings
    • 12.9.3 Key Financial Summary
  • 12.10 Trinity Biotech plc
    • 12.10.1 Business Overview
    • 12.10.2 Product and Service Offerings
    • 12.10.3 Key Financial Summary
  • 12.11 bioMerieux S.A.
    • 12.11.1 Business Overview
    • 12.11.2 Product and Service Offerings
    • 12.11.3 Key Financial Summary
  • 12.12 A. Menarini Diagnostics S.r.l.
    • 12.12.1 Business Overview
    • 12.12.2 Product and Service Offerings
  • 12.13 Cambridge Life Sciences Limited
    • 12.13.1 Business Overview
    • 12.13.2 Product and Service Offerings
  • 12.14 Seramun Diagnostica GmbH
    • 12.14.1 Business Overview
    • 12.14.2 Product and Service Offerings
  • 12.15 Exagen Inc.
    • 12.15.1 Business Overview
    • 12.15.2 Product and Service Offerings
    • 12.15.3 Key Financial Summary
  • 12.16 HYCOR Biomedical
    • 12.16.1 Business Overview
    • 12.16.2 Product and Service Offerings
  • 12.17 ELITech Group
    • 12.17.1 Business Overview
    • 12.17.2 Product and Service Offerings
  • 12.18 Inova Diagnostics
    • 12.18.1 Business Overview
    • 12.18.2 Product and Service Offerings
  • 12.19 Adaltis S.r.l.
    • 12.19.1 Business Overview
    • 12.19.2 Product and Service Offerings
  • 12.20 ORGENTEC Diagnostika GmbH
    • 12.20.1 Business Overview
    • 12.20.2 Product and Service Offerings
  • 12.21 Sigma Diagnostics Inc.
    • 12.21.1 Business Overview
    • 12.21.2 Product and Service Offerings

Chapter 13. Appendix

  • 13.1 Abbreviations
  • 13.2 Sources and References
  • 13.3 Related Reports

LIST OF TABLES

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 5 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 6 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 7 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 8 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 9 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 10 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2019)
  • TABLE 11 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020-2030)
  • TABLE 12 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 13 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 14 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 15 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 16 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY REGION, $M (2014-2019)
  • TABLE 17 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY REGION, $M (2020-2030)
  • TABLE 18 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 19 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 20 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 21 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 22 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 23 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 24 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2019)
  • TABLE 25 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020-2030)
  • TABLE 26 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 27 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 28 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 29 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 30 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 31 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 32 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 33 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 34 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 35 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 36 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 37 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 38 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2019)
  • TABLE 39 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020-2030)
  • TABLE 40 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 41 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 42 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 43 U.S. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 44 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 45 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 46 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 47 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 48 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 49 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 50 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2019)
  • TABLE 51 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020-2030)
  • TABLE 52 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 53 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 54 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 55 CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 56 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 57 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 58 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 59 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 60 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 61 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 62 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2019)
  • TABLE 63 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020-2030)
  • TABLE 64 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 65 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 66 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 67 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 68 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 69 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 70 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 71 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 72 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 73 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 74 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 75 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 76 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2019)
  • TABLE 77 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020-2030)
  • TABLE 78 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 79 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 80 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 81 GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 82 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 83 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 84 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 85 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 86 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 87 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 88 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2019)
  • TABLE 89 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020-2030)
  • TABLE 90 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 91 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 92 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 93 FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 94 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 95 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 96 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 97 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 98 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 99 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 100 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2019)
  • TABLE 101 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020-2030)
  • TABLE 102 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 103 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 104 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 105 U.K. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 106 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 107 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 108 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 109 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 110 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 111 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 112 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2019)
  • TABLE 113 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020-2030)
  • TABLE 114 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 115 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 116 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 117 ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 118 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 119 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 120 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 121 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 122 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 123 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 124 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2019)
  • TABLE 125 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020-2030)
  • TABLE 126 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 127 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 128 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 129 SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 130 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 131 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 132 APAC AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 133 APAC AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 134 APAC AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 135 APAC AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 136 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2019)
  • TABLE 137 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020-2030)
  • TABLE 138 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 139 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 140 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 141 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 142 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 143 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 144 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 145 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 146 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 147 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 148 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 149 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 150 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2019)
  • TABLE 151 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020-2030)
  • TABLE 152 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 153 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 154 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 155 CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 156 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 157 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 158 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 159 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 160 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 161 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 162 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2019)
  • TABLE 163 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020-2030)
  • TABLE 164 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 165 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 166 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 167 INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 168 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 169 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 170 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 171 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 172 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 173 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 174 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2019)
  • TABLE 175 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020-2030)
  • TABLE 176 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 177 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 178 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 179 JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 180 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 181 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 182 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 183 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 184 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 185 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 186 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2019)
  • TABLE 187 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020-2030)
  • TABLE 188 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 189 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 190 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 191 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 192 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 193 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 194 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 195 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 196 MEA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 197 MEA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 198 MEA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 199 MEA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 200 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2019)
  • TABLE 201 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2020-2030)
  • TABLE 202 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 203 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 204 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2019)
  • TABLE 205 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2020-2030)
  • TABLE 206 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 207 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 208 PRODUCT BENCHMARKING OF KEY PLAYERS
  • TABLE 209 ABBOTT LABORATORIES - AT A GLANCE
  • TABLE 210 ABBOTT LABORATORIES - KEY FINANCIAL SUMMARY
  • TABLE 211 BIO-RAD LABORATORIES INC. - AT A GLANCE
  • TABLE 212 BIO-RAD LABORATORIES INC. - KEY FINANCIAL SUMMARY
  • TABLE 213 THERMO FISHER SCIENTIFIC INC. - AT A GLANCE
  • TABLE 214 THERMO FISHER SCIENTIFIC INC. - KEY FINANCIAL SUMMARY
  • TABLE 215 SIEMENS AG - AT A GLANCE
  • TABLE 216 SIEMENS AG - KEY FINANCIAL SUMMARY
  • TABLE 217 GRIFOLS S.A. - AT A GLANCE
  • TABLE 218 GRIFOLS S.A. - KEY FINANCIAL SUMMARY
  • TABLE 219 DANAHER CORPORATION - AT A GLANCE
  • TABLE 220 DANAHER CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 221 F. HOFFMANN-LA ROCHE LTD. - AT A GLANCE
  • TABLE 222 F. HOFFMANN-LA ROCHE LTD. - KEY FINANCIAL SUMMARY
  • TABLE 223 PERKINELMER INC. - AT A GLANCE
  • TABLE 224 PERKINELMER INC. - KEY FINANCIAL SUMMARY
  • TABLE 225 DIASORIN S.P.A. - AT A GLANCE
  • TABLE 226 DIASORIN S.P.A. - PRODUCT AND SERVICE OFFERINGS
  • TABLE 227 DIASORIN S.P.A. - KEY FINANCIAL SUMMARY
  • TABLE 228 TRINITY BIOTECH PLC - AT A GLANCE
  • TABLE 229 TRINITY BIOTECH PLC. - KEY FINANCIAL SUMMARY
  • TABLE 230 BIOMERIEUX S.A. - AT A GLANCE
  • TABLE 231 BIOMERIEUX S.A. - KEY FINANCIAL SUMMARY
  • TABLE 232 A. MENARINI DIAGNOSTICS S.R.L. - AT A GLANCE
  • TABLE 233 CAMBRIDGE LIFE SCIENCES LIMITED - AT A GLANCE
  • TABLE 234 SERAMUN DIAGNOSTICA GMBH - AT A GLANCE
  • TABLE 235 EXAGEN INC. - AT A GLANCE
  • TABLE 236 EXAGEN INC. - KEY FINANCIAL SUMMARY
  • TABLE 237 HYCOR BIOMEDICAL - AT A GLANCE
  • TABLE 238 ELITECH GROUP - AT A GLANCE
  • TABLE 239 INOVA DIAGNOSTICS - AT A GLANCE
  • TABLE 240 ADALTIS S.R.L. - AT A GLANCE
  • TABLE 241 ORGENTEC DIAGNOSTIKA GMBH - AT A GLANCE
  • TABLE 242 SIGMA DIAGNOSTICS INC. - AT A GLANCE

LIST OF FIGURES

  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 6 DATA TRIANGULATION APPROACH
  • FIG 7 CURRENCY CONVERSION RATES FOR USD (2019)
  • FIG 8 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SUMMARY
  • FIG 9 BARGAINING POWER OF BUYERS
  • FIG 10 BARGAINING POWER OF SUPPLIERS
  • FIG 11 INTENSITY OF RIVALRY
  • FIG 12 THREAT OF NEW ENTRANTS
  • FIG 13 THREAT OF SUBSTITUTES
  • FIG 14 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SNAPSHOT
  • FIG 15 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 16 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2030)
  • FIG 17 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2030)
  • FIG 18 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2030)
  • FIG 19 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 20 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2030)
  • FIG 21 WORLDWIDE MAJOR MARKETS FOR AUTOIMMUNE DISEASE DIAGNOSTICS PRODUCTS
  • FIG 22 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY REGION, $M (2014-2030)
  • FIG 23 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SNAPSHOT
  • FIG 24 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 25 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2030)
  • FIG 26 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2030)
  • FIG 27 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2030)
  • FIG 28 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 29 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2030)
  • FIG 30 NORTH AMERICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 31 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SNAPSHOT
  • FIG 32 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 33 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2030)
  • FIG 34 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2030)
  • FIG 35 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2030)
  • FIG 36 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 37 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2030)
  • FIG 38 EUROPE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 39 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SNAPSHOT
  • FIG 40 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 41 APAC AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2030)
  • FIG 42 APAC AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2030)
  • FIG 43 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2030)
  • FIG 44 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 45 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2030)
  • FIG 46 APAC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 47 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SNAPSHOT
  • FIG 48 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 49 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2030)
  • FIG 50 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2030)
  • FIG 51 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2030)
  • FIG 52 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 53 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2030)
  • FIG 54 LATAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 55 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SNAPSHOT
  • FIG 56 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 57 MEA AUTOIMMUNE DISEASE DIAGNOSTICS CONSUMABLES AND ASSAY KITS MARKET, BY TYPE, $M (2014-2030)
  • FIG 58 MEA AUTOIMMUNE DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, $M (2014-2030)
  • FIG 59 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, $M (2014-2030)
  • FIG 60 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 61 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY END USER, $M (2014-2030)
  • FIG 62 MEA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 63 GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SHARE ANALYSIS OF KEY PLAYERS (2019)
  • FIG 64 ABBOTT LABORATORIES - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 65 BIO-RAD LABORATORIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 66 THERMO FISHER SCIENTIFIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 67 SIEMENS AG - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 68 GRIFOLS S.A. - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2019)
  • FIG 69 DANAHER CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 70 F. HOFFMANN-LA ROCHE LTD. - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2019)
  • FIG 71 PERKINELMER INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 72 DIASORIN S.P.A. - REVENUE SPLIT BY TECHNOLOGY AND GEOGRAPHY (2019)
  • FIG 73 TRINITY BIOTECH PLC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 74 BIOMÉRIEUX S.A. - REVENUE SPLIT BY APPLICATION AND GEOGRAPHY (2018)